Hyderabad, March 14,2014: According to the US Food and Drug Administration, the Hyderabad-based company was recalling 58,656 bottles of the drug due to a microbial contamination.

The recall has been classified as ‘Class II’, which, as per FDA norms, is not a serious problem, with only a remote chance of severe adverse consequences from contamination in the product.

A Dr Reddy’s spokesperson said that it was a voluntary recall and that there was no financial implication.

On the Bombay Stock Exchange, the Dr Reddy’s scrip ended Thursday at Rs. 2,734, up 1.63 per cent.


Please enter your comment!
Please enter your name here